Lipo-PGE1

DRUG3 trials

Sponsors

First Affiliated Hospital, Sun Yat-Sen University, West China Hospital, Tongji Hospital

Conditions

Coronary Microvascular Perfusion in Patients With Ischemic Heart DiseaseDiabetic NephropathyPercutaneous Coronary InterventionProstaglandin E1

Phase 3

Protective Effect of Lipo-PGE1 on Myocardial Injury Following Percutaneous Coronary Intervention

First Affiliated Hospital, Sun Yat-Sen UniversityPercutaneous Coronary Intervention, Prostaglandin E1

Start: 2011-01-31End: 2011-12-31Target: 100Updated: 2010-11-23

Phase 4

Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy

CompletedNCT02628106

West China HospitalDiabetic Nephropathy

Start: 2015-12-31End: 2016-02-29Updated: 2016-12-29

PGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and Diabetes

Tongji HospitalCoronary Microvascular Perfusion in Patients With Ischemic Heart Disease

Start: 2017-01-31End: 2018-03-31Target: 60Updated: 2017-05-18